Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sanuwave Health ( (SNWV) ) just unveiled an update.
On May 30, 2025, Sanuwave Health, Inc. terminated its former Chief Commercial Officer, Nanci Gilmore, without cause. Subsequently, on July 28, 2025, Ms. Gilmore and the company reached a Separation and Release Agreement, which includes a lump sum payment and continuation of stock option vesting, along with confidentiality and non-disparagement clauses.
The most recent analyst rating on (SNWV) stock is a Buy with a $49.00 price target. To see the full list of analyst forecasts on Sanuwave Health stock, see the SNWV Stock Forecast page.
Spark’s Take on SNWV Stock
According to Spark, TipRanks’ AI Analyst, SNWV is a Neutral.
Sanuwave Health’s overall stock score reflects strong technical momentum and promising earnings guidance, but significant financial challenges and a negative valuation score weigh heavily. While there is potential for growth, the company’s profitability and financial stability issues present substantial risks.
To see Spark’s full report on SNWV stock, click here.
More about Sanuwave Health
Average Trading Volume: 83,444
Technical Sentiment Signal: Buy
Current Market Cap: $297.9M
See more data about SNWV stock on TipRanks’ Stock Analysis page.